Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Droxidopa for symptomatic neurogenic orthostatic hypotension
2008-002855-26Phase 3Completed
- Sponsor
- Chelsea Therapeutics International, Ltd.
- Start
- Jun 2008
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in Neurogenic Orthostatic Hypotension (nOH) comparing Droxidopa with Placebo (2 arms). Primary endpoint: Relative mean change in OHSA Item 1 score. Started Jun 2008; status: completed.
02
Drugs
droxidopa
03
Conditions
Neurogenic Orthostatic Hypotension (nOH)
Beyond the preview
Go deeper on 2008-002855-26.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-002855-26.